Choroid Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-11-2024
- Paid Up Capital ₹ 2.00 M
as on 16-11-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.68 Cr
as on 16-11-2024
- Satisfied Charges ₹ 7.00 M
as on 16-11-2024
- Revenue 20.35%
(FY 2023)
- Profit 61.93%
(FY 2023)
- Ebitda -3.63%
(FY 2023)
- Net Worth 8.07%
(FY 2023)
- Total Assets 12.95%
(FY 2023)
About Choroid Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹2.68 Cr. The company has closed loans amounting to ₹7.00 M, as per Ministry of Corporate Affairs (MCA) records.
Saurabh Sehgal and Poonam Grover serve as directors at the Company.
- CIN/LLPIN
U51909HR2013PTC050890
- Company No.
050890
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Kurukshetra, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Choroid Laboratories Private Limited offer?
Choroid Laboratories Private Limited offers a wide range of products and services, including Common Disease Medicines, Eye Care Medicines, Ear Drops, Brain & Nervous System Drugs, Antiepileptic Drugs, Antibacterial Drugs, Ofloxacin Tablet IP, Antidepressant & Anti Anxiety Medicines, Amitriptyline Tablet, Psychotherapeutic Agents.
Who are the key members and board of directors at Choroid Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Sehgal  | Director | 11-Nov-2013 | Current |
| Poonam Grover | Director | 11-Nov-2013 | Current |
Financial Performance of Choroid Laboratories.
Choroid Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.35% increase. The company also saw a substantial improvement in profitability, with a 61.93% increase in profit. The company's net worth moved up by a moderate rise of 8.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Choroid Laboratories?
In 2023, Choroid Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ciliary Healthcare Private LimitedActive 3 years 8 monthsSaurabh Sehgal and Poonam Grover are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Sep 2024 | ₹8.00 M | Open |
Others Creation Date: 22 Feb 2021 | ₹4.50 M | Open |
Hdfc Bank Limited Creation Date: 30 Sep 2019 | ₹1.43 Cr | Open |
How Many Employees Work at Choroid Laboratories?
Unlock and access historical data on people associated with Choroid Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Choroid Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Choroid Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
